Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2009
Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindranceSheng Li, Hao Wang, Baozhen Peng, et al.Cancer Drug Resistance (Alhambra, Calif.)|September 13, 2024
The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancerMeilan Zhang, Zhaokuan Zheng, Shouliang Wang, et al.Annals of Biomedical Engineering|March 3, 2025
Identification of Novel Biomarkers for Malignant Thyroid Nodules: A Preliminary Study Based on Ultrasound OmicsZufei Li, Kaifeng Wang, Junpu Qu, et al.Frontiers in Immunology|January 30, 2026
The role of immune checkpoint molecules in cancersMeilan Zhang, Junjie Xu, Zhaokuan Zheng, et al.The Journal of Biological Chemistry|March 31, 2007
Structural basis for recognition of CD20 by therapeutic antibody RituximabJiamu Du, Hao Wang, Chen Zhong, et al.Scientific Reports|September 6, 2018
Structural basis for the complete resistance of the human prion protein mutant G127V to prion diseaseZhen Zheng, Meilan Zhang, Yongheng Wang, et al.Gland Surgery|January 17, 2025
Intranodular and perinodular ultrasound radiomics distinguishes benign and malignant thyroid nodules: a multicenter studyXuelin Zhu, Jing Li, Hao Li, et al.Molecular Immunology|March 19, 2008
Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptideJiamu Du, Hao Wang, Chen Zhong, et al.Oncology Letters|February 14, 2018
A rare e14a3 BCR/ABL fusion transcript in acute lymphoblastic leukemia patient treated with CAR-modified T-cell therapyHaodong Cai, Li Yang, Kefeng Shen, et al.Frontiers in Oncology|November 7, 2022
Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case reportKefeng Shen, Meilan Zhang, Jiachen Wang, et al.Pageof 7